Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 28 August

Grady Wulff
August 28, 2023

Weekly Wrap 25 August

Grady Wulff
August 25, 2023

Morning Bell 25 August

Sam Kanaan
August 25, 2023

Morning Bell 24 August

Grady Wulff
August 24, 2023

Morning Bell 23 August

Grady Wulff
August 23, 2023

Morning Bell 22 August

Sam Kanaan
August 22, 2023

Morning Bell 21 August

Grady Wulff
August 21, 2023

Weekly Wrap 18 August

Grady Wulff
August 18, 2023

Morning Bell 18 August

Sam Kanaan
August 18, 2023

Morning Bell 17 August

Grady Wulff
August 17, 2023

Morning Bell 16 August

Grady Wulff
August 16, 2023